The US cardiac catheter market is estimated to grow significantly during the forecast period. The market is mainly driven due to the increasing prevalence of CVD in the country couped with technological advancement in catheter technology further propel the growth of the market. According to the American Heart Association (AHA) in 2017, CVD accounts for approximately 800,000 mortalities in the US that is one out of three mortalities. Among every Americans an average of one person dies from CVD every 40 seconds. Coronary heart disease (CHD) accounts for the majority of CVD mortalities, followed by stroke and heart failure. More than 90 million Americans carry a diagnosis of CVD. As per AHA, on a global level, CVD accounts for 31% of all mortalities in 2017. Moreover, 41.5% of the US population had at least one cardiovascular condition: High Blood Pressure (96.1 million), CHD (16.8), Stroke (7.5 million), Congestive Heart Failure (5.8 million), and Atrial Fibrillation (5.2 million).
The US cardiac catheter market is segmented on the basis of type and end-user. Based on type, the market is segregated angiographic catheters, PTCA dilatation catheters, guiding catheters, and others. Angiographic catheters are widely adopted type in the cardiac catheter market and have a considerable market share. On the basis of end-user, the market is classified into hospitals & clinics and ambulatory surgical centers. Hospitals & clinics are one of the major end-users for cardiac catheter as there are a large number of heart surgeries conducted in hospitals. In hospitals, catheters are widely used in the angioplasty procedure for treating heart patients. Hospitals and diagnostic clinics use the sensor-enabled cardiac catheters to diagnose the congenital heart defect, to check narrow and blocked blood vessels, to inspect the functioning of a heart valve, to measure the pressure inside the heart and to perform tissue biopsy from the heart.
The companies which are contributing to the growth of the US cardiac catheter market include Abbott Laboratories, Boston Scientific Corp, Biosense Webster, Inc. (Johnson & Johnson Services, Inc.)., Koninklijke Philips N.V., Medtronic PLC, Edwards Lifesciences Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
Research Methodology
The market study of the US cardiac catheter market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. US Cardiac Catheters Market by Type
5.1.1. Angiographic Catheters
5.1.2. PTCA Dilatation Catheters
5.1.3. Guiding Catheters
5.1.4. Others (Intravascular Ultrasound (IVUS) Catheters)
5.2. US Cardiac Catheters Market by End-User
5.2.1. Hospitals and Clinics
5.2.2. Ambulatory Surgical Centers
6. Company Profiles
6.1. Abbott Laboratories
6.2. Biosense Webster, Inc. (Johnson & Johnson Services, Inc.)
6.3. Biotronik, Inc.
6.4. Boston Scientific Corp.
6.5. Cook Group Inc.
6.6. Edwards Lifesciences Corp.
6.7. ICU Medical, Inc.
6.8. Koninklijke Philips N.V.
6.9. Medtronic PLC
6.10. Merit Medical Systems, Inc.
6.11. Terumo Group
1. US CARDIAC CATHETERS MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
2. US CARDIAC CATHETERS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
1. US CARDIAC CATHETERS MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. US CARDIAC CATHETERS MARKET SHARE BY END-USER, 2018 VS 2025 (%)